Skip to content

Clinical trials

Completed Phase 2 Mood Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Phase: Phase 2 Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20031
20043
20072
20083
20091
20101
20113
20121
20131
20141
20173
20192
20204
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)9
Marinus Pharmaceuticals2
University of North Carolina, Chapel Hill2
University of Texas Southwestern Medical Center2
VA Office of Research and Development2
Bayside Health1
Brain and Cognition Discovery Foundation1
Brigham and Women's Hospital1
Brown University1
Centre Hospitalier Universitaire de Besancon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders40
Major Depressive Disorder17
Bipolar Disorder12
Depressive Disorder12
Mental Disorders12
Psychotic Disorders4
Anxiety Disorders3
Depression, Postpartum3
Mania3
Attention Deficit and Disruptive Behavior Disorders2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.